Literature DB >> 21588735

(2E)-3-[4-(Dimethyl-amino)-phen-yl]-1-(2,5-dimethyl-3-thien-yl)prop-2-en-1-one.

Abdullah M Asiri, Salman A Khan, M Nawaz Tahir.   

Abstract

The asymmetric unit of the title compound, C(17)H(19)NOS, contains two independent mol-ecules which differ in the dihedral angles between the five- and six-membered rings [12.52 (10) and 4.63 (11)°]. Weak inter-molecular C-H⋯O hydrogen bonds link the two independent mol-ecules into pseudocentrosymmetric dimers. In one mol-ecule, the O atom of the carbonyl group is disordered over two positions in a 0.699 (4):0.301 (4) ratio.

Entities:  

Year:  2010        PMID: 21588735      PMCID: PMC3008074          DOI: 10.1107/S1600536810033751

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  (2E)-3-(3,4-Dimeth-oxy-phen-yl)-1-(2,5-dimethyl-thio-phen-3-yl)prop-2-en-1-one.

Authors:  Abdullah M Asiri; Salman A Khan; M Nawaz Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-31

3.  (E)-1-(2,5-Dimethyl-3-thien-yl)-3-(2,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Abdullah M Asiri; Salman A Khan; M Nawaz Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-24

4.  (E)-1-(2,5-Dimethyl-3-thien-yl)-3-(2-hy-droxy-phen-yl)prop-2-en-1-one.

Authors:  Abdullah M Asiri; Salman A Khan; M Nawaz Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  1 in total

1.  (2E)-1-(2,5-Dimethyl-thio-phen-3-yl)-3-(3-nitro-phen-yl)prop-2-en-1-one.

Authors:  Abdullah M Asiri; Abdulrahman O Al-Youbi; Salman A Khan; M Nawaz Tahir
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.